The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Methods Of Treating Lennox-Gastaut Syndrome Using Fenfluramine - EP3340971

The patent EP3340971 was granted to Zogenix on Mar 13, 2024. The application was originally filed on Aug 24, 2016 under application number EP16840062A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3340971

ZOGENIX
Application Number
EP16840062A
Filing Date
Aug 24, 2016
Status
Granted And Under Opposition
Feb 9, 2024
Publication Date
Mar 13, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBNov 19, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2006270611
INTERNATIONAL-SEARCH-REPORTUS2011092535
INTERNATIONAL-SEARCH-REPORTUS2011212171
INTERNATIONAL-SEARCH-REPORTUS2014343162
INTERNATIONAL-SEARCH-REPORTWO2014177676
OPPOSITIONUS2016092652
OPPOSITIONWO2015026849

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents